In tonight’s Avera Medical Minute, we introduce you to a Sioux Falls woman who thanks her mother’s intuition for helping ...

If you or a loved one is suffering from gastrointestinal issues, your doctor may recommend an EndoFLIP procedure. This diagnostic tool offers accurate measurements of the area and pressure within ...

Eosinophilic esophagitis is a chronic, progressive disease in which the esophagus becomes inflamed due to a buildup of eosinophils, creating difficulty swallowing and eating. Dupilumab is a monoclonal ...

Eosinophilic esophagitis is a chronic inflammatory disorder in which eosinophils, a type of white blood cell, proliferate in the esophagus, causing difficulties with eating and swallowing. The FDA ...

Please provide your email address to receive an email when new articles are posted on . ‘1104 aims for long-term disease remission without immunity suppression. Healthy volunteers tolerated 16 mg, 32 ...

The FDA has approved the use of dupilumab for treating eosinophilic esophagitis in adults and children aged 12 years and older, making it the first drug in the U.S. specifically indicated for this ...

A one-food elimination diet (1FED) could be just as effective as the popular six-food elimination diet (6FED) for patients suffering from eosinophilic esophagitis (EoE), a randomized trial showed.

DEAR DR. ROACH: After reading your recent column on difficulty swallowing, I wanted to write in about my experience with dysphagia. An endoscopy with dilation and biopsies confirmed that I had ...

Credit: Phathom Pharmaceuticals. Vonoprazan is an oral small molecule potassium-competitive acid blocker. The Food and Drug Administration (FDA) has approved Voquezna (vonoprazan) for healing and ...

A 70-year-old woman developed severe reflux oesophagitis and ulceration after months of semaglutide use, highlighting the potential gastrointestinal risks.